Divalproex Sodium Tablet, Delayed Release
Product Images NDC 29300-140

9 FDA label images from Unichem Pharmaceuticals (usa), Inc. · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 9 technical images submitted to the FDA as part of the official labeling for Divalproex Sodium (NDC 29300-140). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Unichem Pharmaceuticals (usa), Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image (674e58bd F580 4805 A7e2 Febcaa37bca5 01)

Image (674e58bd F580 4805 A7e2 Febcaa37bca5 01)
Chemical structure of Divalproex Sodium depicting its molecular arrangement with sodium ions and structural groups. The diagram shows the repeating unit composition of the compound.*
FDA Label Image

Image (674e58bd F580 4805 A7e2 Febcaa37bca5 02)

Image (674e58bd F580 4805 A7e2 Febcaa37bca5 02)
A bar chart comparing percentages for two studies labeled Study 1 and Study 2, with groups PBO and DVPX. Study 1 shows 26% for PBO and 60% for DVPX; Study 2 shows 29% for PBO and 58% for DVPX. The vertical axis represents percentage values from 0% to 70%.*
FDA Label Image

Image (674e58bd F580 4805 A7e2 Febcaa37bca5 03)

Image (674e58bd F580 4805 A7e2 Febcaa37bca5 03)
A cumulative percentage plot comparing percent reduction in CPS rate between Divalproex Sodium and placebo over a patient population. The y-axis shows percent reduction in CPS rate from -100% worsening to 100% improvement, and the x-axis represents the percentage of patients, descending from 100% to 0%. Divalproex Sodium is depicted with a solid line and placebo with a dotted line, illustrating higher improvement rates for Divalproex Sodium.*
FDA Label Image

Image (674e58bd F580 4805 A7e2 Febcaa37bca5 04)

Image (674e58bd F580 4805 A7e2 Febcaa37bca5 04)
A line graph showing the percentage reduction in CPS (Clinical Parameter Score) rate plotted against the percentage of patients. It compares high dose and low dose groups of a medication, with improvement indicated by positive reduction percentages and worsening by negative values. The high dose group is represented by a solid line, and the low dose group by a dashed line.*
FDA Label Image

Image (674e58bd F580 4805 A7e2 Febcaa37bca5 05)

Image (674e58bd F580 4805 A7e2 Febcaa37bca5 05)
A bar chart comparing the effects of Placebo and Divalproex Sodium in two studies. Study 1 shows higher values for Placebo compared to Divalproex Sodium. Study 2 also shows higher values for Placebo compared to Divalproex Sodium, with both comparisons presented side by side for each study.*
FDA Label Image

Image (8e888ed9 2d55 4e95 Ba7b 8b437481c947 1830 2)

FDA Label Image

Divalproex Sodium Delayed Release Tablets Usp, 125 mg-100t (674e58bd F580 4805 A7e2 Febcaa37bca5 06)

Divalproex Sodium Delayed Release Tablets Usp, 125 mg-100t (674e58bd F580 4805 A7e2 Febcaa37bca5 06)
Label for Divalproex Sodium delayed release tablets, USP, 125 mg strength. The label indicates a package of 100 tablets, prescription only, manufactured by Unichem Laboratories Ltd. in India and labeled for Unichem Pharmaceuticals (USA), Inc. The label includes storage instructions, barcode, and a note about dispensing a medication guide to patients.*
FDA Label Image

Divalproex Sodium Delayed Release Tablets Usp, 250 mg-100t (674e58bd F580 4805 A7e2 Febcaa37bca5 07)

Divalproex Sodium Delayed Release Tablets Usp, 250 mg-100t (674e58bd F580 4805 A7e2 Febcaa37bca5 07)
Label for Divalproex Sodium delayed release tablets, USP, 250 mg strength, oral dosage form. The label states prescription use only with a quantity of 100 tablets. It includes storage instructions at 20° to 25°C, dispensing guidance, and notes on packaging integrity. Manufactured by Unichem Laboratories Ltd., Ghaziabad, India, and labeled for Unichem Pharmaceuticals (USA), Inc.*
FDA Label Image

Divalproex Sodium Delayed Release Tablets Usp, 500 mg-100t (674e58bd F580 4805 A7e2 Febcaa37bca5 08)

Divalproex Sodium Delayed Release Tablets Usp, 500 mg-100t (674e58bd F580 4805 A7e2 Febcaa37bca5 08)
Label for Divalproex Sodium Delayed Release Tablets, USP 500 mg by Unichem Pharmaceuticals (USA), Inc. The label specifies the tablet is enteric-coated and contains 500 mg of valproic acid activity. It notes storage instructions at 20° to 25°C and packaging in a light-resistant container. The package contains 100 tablets and is marked Rx Only. Manufacturer information and barcode are included.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.